Skip to main content

Pre-analytical factors in clinical proteomics investigations: impact of ex vivo protein modifications for multiple sclerosis biomarker discovery.

Pieragostino D, Petrucci F, Del Boccio P, Mantini D, Lugaresi A, Tiberio S, Onofrj M, Gambi D, Sacchetta P, Di Ilio C, Federici G, Urbani A

Publication: J Proteomics (2010) • Vol 73 • Page 579-92PMID: 19666151View on PubMed

Purpose

The purpose of this paper was to determine the effects of storage temperature and duration on the low molecular weight peptide profiles of serum from healthy individuals and patients with multiple sclerosis (MS).

Conclusion

Serum peptide profiles were unaffected by storage of serum at -80 degrees C for up to 2 years, but peptide profiles were significantly affected by storage at -20 degrees C for more than 48 h, or at 4 degrees C or room temperature for more than 4 h compared to peptide profiles of fresh serum. An increasing number of new peaks were identified with increasing storage at -20 degrees C, but the specific peaks were different in serum from patients with MS and healthy individuals.

Studies (1)

Purpose

The purpose of this study was to determine the effects of storage temperature and duration on low molecular weight peptide profiles of serum from healthy individuals and patients with MS. MALDI-TOF analysis was conducted using sinapinic acid as the matrix, trifluoroacetic acid (TFA) ionic coupling and Zip-Tip C4 for solid extraction. The authors report that hemoglobin was detected in all serum specimens due to hemolysis.

Summary of Findings

Serum peptide profiles were unaffected by storage of serum at -80 degrees C for up to 2 years, but the peptide profiles were significantly affected by storage at -20 degrees C for more than 48 h, or at 4 degrees C or room temperature for more than 4 h compared to peptide profiles of fresh serum. While a small insignificant number of additional peaks were found in frozen specimens (-20 or -80 degrees C) compared to fresh specimens, the number of additional peaks increased only with increasing storage at -20 degrees C and remained constant when serum was stored at -80 degrees C. Principle component analysis (PCA) was able to distinguish between fresh serum from individuals with MS and healthy controls, and PCA distinguished fresh specimens from frozen specimens. Interestingly, the peaks that distinguished fresh and frozen specimens stored at -20 degrees C for 20 days were different in the MS and the healthy groups. Using HPLC, the affected peptides were identified to be apolipoprotein A-IV, complement C3, transthyretin, anaphylatoxin, apolipoprotein CII, and apolipoprotein CIII.

  • Biospecimens

    FluidSerum
    FluidBlood
  • Preservation Types

    None (Fresh)Frozen
  • Diagnoses

    Multiple Sclerosis
    Normal
  • Platforms

    PeptideMALDI-TOF MS
    ProteinMALDI-TOF MS
  • Pre-analytical Factors

    ClassificationPre-Analytical FactorValue(s)
    PreaquisitionDiagnosis/ patient condition
    Healthy
    MS
    Biospecimen PreservationType of fixation/preservation
    Frozen
    None (fresh)
    StorageStorage duration
    0 h
    10 days
    2 years
    20 days
    24 h
    3 months
    4 h
    48 h
    5 months
    StorageStorage temperature
    -20 degrees C
    -80 degrees C
    23 degrees C
    4 degrees C